Flaws in analysis lead to misleading conclusions about varenicline's safety in smoking cessation

BMJ. 2012 Jun 12:344:e3873; author reply e4033. doi: 10.1136/bmj.e3873.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzazepines / adverse effects*
  • Cardiovascular Diseases / chemically induced*
  • Female
  • Humans
  • Male
  • Nicotinic Agonists / adverse effects*
  • Quinoxalines / adverse effects*
  • Tobacco Use Cessation / methods*

Substances

  • Benzazepines
  • Nicotinic Agonists
  • Quinoxalines